CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.12 ($41,200)
- 4 Other acquisition COO & CFO acquired 800 shares (other)
- 4 Open-market buy Director bought 900 shares at $4.22 ($3,798)
- 4 Open-market buy Director bought 2,000 shares at $4.21 ($8,420)
- 4 Open-market buy Chief Executive Officer bought 4,000 shares at $4.21 ($16,840)
- 4 Open-market buy Director bought 10,000 shares at $4.28 ($42,800)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.27 ($42,700)
- 4 Open-market buy Director bought 50,000 shares at $4.09 ($204,500)
- 4 Open-market buy Director bought 2,000 shares at $4.05 ($8,100)
- 4 Open-market buy Chief Executive Officer bought 11,000 shares at $3.90 ($42,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy COO & CFO bought 2,250 shares at $4.45 ($10,013)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $4.08 ($12,240)
- 4 Open-market buy Director bought 5,000 shares at $3.98 ($19,900)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $3.84 ($11,520)
- 4 Open-market buy Chief Executive Officer bought 4,112 shares at $3.96 ($16,284)
Page 9 of 24 · 471 filings